High Density Lipoproteins : From Biological Understanding to Clinical Exploitation / edited by Arnold von Eckardstein, Dimitris Kardassis.
Contributor(s): von Eckardstein, Arnold, editor literario
| Kardassis, Dimitris, editor literario
| SpringerLink (Online service)
Material type:
E-bookSeries: Handbook of Experimental Pharmacology; 224224Publisher: Cham, Switzerland : Springer, 2015Description: 1 recurso en línea (XIII, 694 p.) : 40 ilustraciones, 37 ilustraciones en color.ISBN: 9783319096650.Subject: Lipoproteínas
| Item type | Current library | Collection | Call number | Copy number | Status | Date due | Barcode | Item holds | |
|---|---|---|---|---|---|---|---|---|---|
LIBRO-E NO PRÉSTAMO
|
Madrid Digital Acceso Electrónico (UEM) | Ciencias de la Salud | QP99.3.H53 2015 EB (Browse shelf(Opens below)) | .i11568033 | Acceso electrónico | eBOOK .i11568033 |
Browsing Madrid Digital shelves, Shelving location: Acceso Electrónico (UEM) Close shelf browser (Hides shelf browser)
| QP99.3.A65 A665 2015 EB Apolipoprotein Mimetics in the Management of Human Disease | QP99.3.B5 2020 EB Glucose Sensor Use in Children and Adolescents : A Practical Guide | QP99.3.G3 T448 2015 EB The Vertebrate Blood-Gas Barrier in Health and Disease : Structure, Development and Remodeling | QP99.3.H53 2015 EB High Density Lipoproteins : From Biological Understanding to Clinical Exploitation | QP99.3 .O9 2017 EB Oxygen transport to tissue XXXIX | QP99.3.O9 2018 EB Oxygen Transport to Tissue XL | QP99.3.O9 2018 EB Oxygen Transport to Tissue XL |
Preface -- Part 1. Physiology of HDL -- Part 2. Pathology of HDL -- Part 3. Possible Indications and Target Mechanisms of HDL Therapy -- Part 4. Treatments for Dyslipidemias and Dysfunction of HDL.
Open Access
In this Handbook of Experimental Pharmacology on “High Density Lipoproteins â€{u09B2}om biological understanding to clinical exploitationâ€{u08EF}ntributing authors (members of COST Action BM0904/HDLnet) summarize in more than 20 chapters our current knowledge on the structure, function, metabolism and regulation of HDL in health and several diseases as well as the status of past and ongoing attempts of therapeutic exploitation. The book is of interest to researchers in academia and industry focusingÂ{uFBA0}lipoprotein metabolism, cardiovascular diseases and immunology as well as clinical pharmacologists, cardiologists, diabetologists, nephrologists and other clinicians interested in metabolic or inflammatory diseases.
There are no comments on this title.